Phio Pharmaceuticals CEO Robert J. Bitterman acquires $2,057.80 in common shares
PHIO•CEO buys additional shares
- Phio Pharmaceuticals Chairman, President, CEO Robert J. Bitterman bought 2,000 common shares in an open-market purchase.
- Purchase price: $1.03 per share.
- Direct holdings increased to 364,871 common shares following the transaction.
